Products Evinacumab
Evinacumab Pre-clinical Completed 💤 Quiet Pediatric Homozygous Familial Hypercholesterolemia (HoFH)
Pediatric Homozygous Familial Hypercholesterolemia (HoFH), Severe Hypertriglyceridemia (HTG), Dysbetalipoproteinemia (DBL)
About Evinacumab Evinacumab is a pre-clinical stage product being developed by Regeneron Pharmaceuticals for Pediatric Homozygous Familial Hypercholesterolemia (HoFH). The current trial status is completed. This product is registered under clinical trial identifier NCT06500598. Target conditions include Pediatric Homozygous Familial Hypercholesterolemia (HoFH), Severe Hypertriglyceridemia (HTG), Dysbetalipoproteinemia (DBL).
Clinical Trials (4) NCT ID Phase Status Start Completion Indication NCT06500598 Pre-clinical Completed — — Pediatric Homozygous Familial Hypercholesterolemia (HoFH) NCT04863014 Phase 2 Terminated Jul 12, 2021 Feb 15, 2023 Hypertriglyceridemia NCT04233918 Phase 3 Completed Jun 29, 2020 May 30, 2023 Homozygous Familial Hypercholesterolemia NCT03409744 Phase 3 Completed Mar 13, 2018 Apr 13, 2023 Homozygous Familial Hypercholesterolemia
Competing Products 20 competing products in Pediatric Homozygous Familial Hypercholesterolemia (HoFH)
See all competitors Product Company Stage Hype Score Ramucirumab Eli Lilly Phase 1 erlotinib + etoposide Astellas Pharma Phase 2 Mitoxantrone Hydrochloride Liposome + Irinotecan + Vincristine Sun Pharmaceutical Phase 1 Perampanel Oral Suspension + Perampanel Tablet Eisai Phase 2 Eribulin Mesylate Eisai Phase 1 Decitabine + Decitabine Eisai Phase 2 Dasotraline 1 mg, 2 mg, 4 mg, 8 mg, 12 mg, 16 mg, 20 mg, 24 mg, 28 mg, 32 mg once daily Sumitomo Pharma Phase 1 Remimazolam Tosilate for injection + Propofol Injection Jiangsu Hengrui Medicine Phase 2/3 Ceftaroline fosamil + Vancomycin +/- Aztreonam or Cefazolin +/- Aztreonam + Cephalexin or Clindamycin or Linezolid AstraZeneca Phase 2/3 candsartan cilexetil AstraZeneca Phase 3 Durvalumab / Tremelimumab Combination Therapy AstraZeneca Phase 1/2 Rotavirus Vaccine Merck Pre-clinical basiliximab, MMF(mycophenolate mofetil), cyclosporine, prednisone (or equivalent) + MMF, cyclosporine, steroids Novartis Phase 3 VAL489 + VAL489 matching placebo Novartis Phase 3 LCZ696 + Enalapril + Placebo of LCZ696 + Placebo of Enalapril + LCZ696 Novartis Phase 2/3 Everolimus Novartis Phase 2 Corticosteroids + Cyclosporine + mycophenolate mofetil Roche Phase 2 Entecavir + Lamivudine + Pegylated Interferon Alfa-2A Roche Phase 3 Blinatumomab for Injection Amgen Phase 1 Etanercept Amgen Phase 3
Other Products from Regeneron Pharmaceuticals